Director of company (BCPC) granted 870 restricted common shares

Rhea-AI Filing Summary

Kathleen B. Fish, a director of the issuer with ticker BCPC, received a grant of 870 shares of common stock on February 11, 2026. The filing classifies this as an acquisition of non-derivative securities at a price of $0 per share.

The 870 shares are restricted stock that will vest one year after the grant date, and are subject to transfer restrictions under a Restricted Stock Grant Agreement between the company and the director. Following this award, Fish beneficially owns 3,429 shares of common stock directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fish Kathleen B

(Last) (First) (Middle)

C/O BALCHEM CORPORATION

5 PARAGON DRIVE

(Street)

MONTVALE NJ 07645

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BALCHEM CORP [ BCPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		A		870(1)	A	$0	3,429	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

	/s/ Travis Larsen, Attorney in Fact for Kathleen B Fish	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BCPC report for director Kathleen B. Fish?

BCPC reported that director Kathleen B. Fish received a grant of 870 shares of common stock on February 11, 2026. This was classified as an acquisition of non-derivative securities at a price of $0 per share under a restricted stock award.

How many BCPC shares does Kathleen B. Fish own after this Form 4 transaction?

After the reported transaction, Kathleen B. Fish beneficially owns 3,429 shares of BCPC common stock directly. This total reflects the additional 870 restricted shares granted on February 11, 2026, as disclosed in the Form 4 insider filing.

What are the vesting terms of the restricted BCPC stock granted to Kathleen B. Fish?

The 870 restricted BCPC shares granted to Kathleen B. Fish vest one year after the grant date. Until vesting, the shares are subject to transfer restrictions specified in a Restricted Stock Grant Agreement between the issuer and the director.

Was the BCPC insider transaction a market purchase or a stock grant?

The BCPC insider transaction was a stock grant, not a market purchase. Form 4 lists the transaction code as a grant, award, or other acquisition at a price of $0 per share, indicating a compensatory restricted stock award to the director.

Is Kathleen B. Fish a 10% owner of BCPC according to this filing?

According to the Form 4, Kathleen B. Fish is reported as a director of BCPC but not as a 10% owner. The reporting person box marks her status as a director only, with the 10% owner designation left unchecked in the filing.